Reneuron Share Discussion Threads

[norbus] 10/5/2016 11:48

Best to trade this in accordance with the spivs who are trying to pump and dump. Get in low, and play covered bear ; that will blow their lid

[alphapig] 09/5/2016 18:12

Woodford may well have bought some at 2.5p, but he bought a much bigger chunk in the 5p placing, he's got over a third of the company at what must be an average over 4p IMHO.Regarding the 35% holding, I guess it must be divided as the holdings rns does include 'clients of woodford'. I don't know the specifics of owning more then 30% of a company in relation to having to make an offer etc.

[norbus] 09/5/2016 17:47

These people create volatility and trade against it with serious money. Mugs get sucked in and lose

[esmerelda] 09/5/2016 16:50

I echo your concerns. Noteworthy spammed many non-related threads with the rose tinted story and I don't think he was being altruistic. I suspect he is looking for any sort of a rise to get out.

[norbus] 09/5/2016 16:22

Beware

A set up for a pump and dump is being established; I have seen it before ; City Chappie, New Tech et al. Noteworthy driving this gang Noteworthy omits to say Woodford bought tons at 2.5p. It will be unpleasant to get back to the hype a few years back ending on collapse . PHE was also hyped as was AFC both now cripples .

[harryrich] 09/5/2016 10:12

good presentations. just bought in as it looks worth more than current price.

[trulyscrumptious] 06/5/2016 11:42

No more spamming please noteworthy.


noteworthy5 6 May'16 - 11:18 - 5473 of 5474 0 1

Check out RENE being a maybe fifty bagger.

Phase 2 and 1 stroke results out this quarter. Retinitis pigmentosa data due Q4. Cancer treatment going into Phase 1 early 2017 and has caused complete tumour collapse within three weeks in preclinical studies.

Michael Hunt's latest presentation for RENE.

19 minutes 30 sec in there is a slide showing RENE's exosome treatment tested preclinical in cancer tumours.



The graph shows the average results of 5 in vitro studies. After 18 - 21 days the tumours completely collapsed. The photos show the same repeated in vivo (with animals) again resulting in tumour collapse. It basically programs the cancer cells "to die". This could be a major breakthrough.

12 minutes onwards MH says the new Exosome treartment has possible use as they unexpectedly found it causes cancer tumour "collapse" after 18 days leaving just "cellular debris". It seems to be "programming cancer cells to adopt a normal cycle of cell death."



Not many people seem to be aware of this but it is another possible multi billion market on top of their blockbusters for stroke and retinitis pigmentosa.

He says they will trial this in humans next year (2017). If it only takes three weeks to be effective they should have early results very quickly. British Biotech went to £2.5 billion on hope for its cancer drug and its worth a bet RENE's will really work.

Include RENE's various treatments for stroke (now ending in Phases 2 and 1) and retinitis pigmentosa (in Phase 1/2) and it could be a fifty bagger.

Former Invesco fund manager Peter Woodford recently increased his stake in RENE to 35% @ 5p.

drjenner01 6 May'16 - 11:32 - 5474 of 5474 1 0

Noteworthy, once is enough, filtered.

[stewart_25] 06/5/2016 10:44

that's a positive post Norbus... temping you ? would love the cancer treatment to work - done quite a bit of fundraising for cancer charities as my mum has had it twice and any grandma died from it... Come on rene... :-)

[norbus] 05/5/2016 15:14

noteworthy 5

Good if the stroke works; expensive so price will enter into market size. Cancer also looks possible ; I got out at 6.6p years ago. maybe tempted to get back

[martinfrench] 05/5/2016 13:03

well glad you all believe me, I'm sure its very important :-)

[dogwalker] 04/5/2016 22:02

Thanks. Your assurance is proof ! And I should have worked out horneb's point too.

[martinfrench] 04/5/2016 19:45

absolutely 100% not a sell dogwalker, and I don't need to prove it, or do I?

[horneblower] 04/5/2016 16:49

With a miniscule amount of trading and a 15% nominal spread, you really can't tell from the price whether it's a buy or a sell.
If I had to bet I would plump for it being a buy.

[dogwalker] 04/5/2016 16:38

Shown as a 'sell' martinfrench : why did you sell, as a matter of interest?

[martinfrench] 04/5/2016 13:57

last 107k trade was mine :-)

[dogwalker] 29/4/2016 12:42

Well, yes. That would certainly bring things forward vis-a-vis the share price.
Thanks, City Chappy.

[city chappy] 29/4/2016 12:17

This is one of the people who took Rene's stroke treatment. It seems to have worked well.



The original BBC page



More results due within weeks. The shares could take off. Add in the exosomes for cancer next year and there could be a feeding frenzy for the stock as the realisation of blockbuster potential gets around.

[noteworthy5] 29/4/2016 12:01

Phase 2 and 1 stroke results out this quarter.

[noteworthy5] 29/4/2016 11:51

The Wiki entry for British Biotech says it was once capitalised at £2.5 billion mainly on hopes for its anti-cancer tumour drug marimastat and that was almost fifteen years ago since when the market and prices have increased. A cross comparison would put RENE on a minimum of 25 times current valuation merely for its exosome cancer treatment.

Michael Hunt's latest presentation for RENE.

19 minutes 30 sec in there is a slide showing RENE's exosome treatment tested preclinical in cancer tumours.



The graph shows the average results of 5 in vitro studies. After 18 - 21 days the tumours completely collapsed. The photos show the same repeated in vivo (with animals) again resulting in tumour collapse. It basically programs the cancer cells "to die". This could be a major breakthrough.

12 minutes onwards MH says the new Exosome treartment has possible use as they unexpectedly found it causes cancer tumour "collapse" after 18 days leaving just "cellular debris". It seems to be "programming cancer cells to adopt a normal cycle of cell death."



Not many people seem to be aware of this but it is another possible multi billion market on top of their blockbusters for stroke and retinitis pigmentosa.

He says they will trial this in humans next year (2017). If it only takes three weeks to be effective they should have early results very quickly. British Biotech went to £2.5 billion on hope for its cancer drug and its worth a bet RENE's will really work.

Add in RENE's various treatments for stroke (currently in Phases 2 and 1) and retinitis pigmentosa (currently in Phase 1/2) and it could be a fifty bagger.

Importantly former Invesco fund manager Peter Woodford recently increased his stake in RENE to 35% @ 5p.

[noteworthy5] 28/4/2016 22:15

Regarding the BBC news RENE are initially treating retinosa pigmentosa not macular degeneration and RENE are already in Phase 1/2a with 2b/3 planned to start in 2017. RENE are using human retinal progenitor cell (hRPC) therapy, not gene therapy. Their cells mature into functioning photoreceptors. RENE have strong in vivo data suggesting their approach works.

Listen at 7 minutes 20 sec

[noteworthy5] 28/4/2016 22:00

Probably a sell freddie.

If it was the same individual or organisation that made the two 900k purchases yesterday that caused the share price to rise it could be market manipulation, i.e. putting through two buys yesterday to make the price rise with the intention of following it today with a much larger sell on the back of the rise. One for the regulators to investigate.


fredd1eboy
28 Apr'16 - 18:19 0 0

Have a look at a late last trade.
TIME 17:05:15
3.125p
19,940,696
£623.15k
It's mid priced, but as far as Im concerned it's a buy

[waterloo01] 28/4/2016 20:52

This looks encouraging.

[small crow] 28/4/2016 10:31

... or be working for Laboratoire Garnier?